Kansai, I cannot explain the decline except to say investors who lack the confidence in SCRC are selling. The buy and sell for a quick profit is also taking place. But my eyes are focused on the future of SCRC with yes, compounding (I bet terms will be negotiated with the PBMs), as well as PIMD, the Diabetes Program, and the recently discussed Physician Dispensing Program. Next Thursday the 19th, Mr. Schneiderman will be presenting at the New York conference. It will be interesting to learn what he discussed in terms of current market conditions, revenues, and future expansion opportunities. I am very confident SCRC will rebound from these dismal last days and will even be stronger.